Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form
As of April 1st VIVO Scientific Profiles will no longer updated for faculty, and the link to VIVO will be removed from the library website. Faculty profile pages will continue to be updated via Interfolio. VIVO will continue being used behind the scenes to update graduate student profiles. Please contact helplib@scripps.edu if you have questions.
How to download citations from VIVO | Alternative profile options

Effects of LPA and S1P on the nervous system and implications for their involvement in disease

Academic Article
uri icon
  • Overview
  • Research
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

authors

  • Herr, D. R.
  • Chun, Jerold

publication date

  • January 2007

journal

  • Current Drug Targets  Journal

abstract

  • Lysophosphatidic acid (LPA) and sphingosine 1-phosphate (S1P) are two well-studied lysophospholipids that are known to be important regulators of cellular events. Their actions are mediated by activating a family of G-protein coupled receptors present in many cell types and tissues. These receptors have diverse biological roles owing to the heterogeneity of their signal transduction pathways. Many of these receptors are expressed in subsets of cells in the developing and mature mammalian nervous system and are thought to have important functions in its formation and maintenance. They are also widely expressed within other organ systems such as the immune system. Growing interest in the field has stimulated the development of a number of molecules that act as agonists or antagonists to LPA and S1P receptors. These molecules may lead to the development of new therapeutic compounds. Indeed, one such compound (FTY720) is currently in clinical trials for use in preventing transplant rejection and treating multiple sclerosis. The purpose of this manuscript is to: 1) review effects elicited by LPA and S1P on cells and tissues with a particular emphasis on the nervous system, 2) examine possible roles of these lipids in the development of disease, and 3) summarize the existing literature describing their agonists/antagonists.

subject areas

  • Animals
  • Humans
  • Lysophospholipids
  • Nervous System
  • Nervous System Diseases
  • Sphingosine
scroll to property group menus

Research

keywords

  • agonists
  • antagonists
  • immune regulation
  • lysophosphatidic acid
  • multiple sclerosis
  • nervous system
  • pain
  • sphingosine 1-phosphate
scroll to property group menus

Identity

International Standard Serial Number (ISSN)

  • 1389-4501

Digital Object Identifier (DOI)

  • 10.2174/138945007779315669

PubMed ID

  • 17266539
scroll to property group menus

Additional Document Info

start page

  • 155

end page

  • 167

volume

  • 8

issue

  • 1

©2022 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support